Amsterdam 2013 Programme Satellite Meetings Registration Exhibition Virtual Exhibition Hotels Visa Letter Invitation
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Comparison of two foldable hydrophobic acrylic single piece IOLs in rabbit model

Poster Details

First Author: M.Toker TURKEY

Co Author(s):    A. Dursun   A. Vural   H. Erdogan   M. Arici   A. Topalkara   O. Arslan

Abstract Details



Purpose:

To compare two foldable hydrophobic acrylic single piece IOLs in rabbit model.

Setting:

Cumhuriyet University, School of Medicine, Department of Ophthalmology, Sivas, Turkey

Methods:

Both eyes of 6 New Zealand albino rabbits were applied phacoemulsification surgery and TECNIS® one-piece lenses were implanted in one eye from a 2.8 mm incision with AMO implantation system and ZARACCOM® ulraflex lenses in the other eye of each rabbits from a 2.2 mm incision with ALCON Monarch III injector systems. Anterior and posterior chamber reactions and posterior capsule opacification(PCO) were evaluated in post operative 6 months test period. Then the rabbits were sacrificed. Histopathologic examinations were applied to the all eyes and lenses.

Results:

At the 4-week dilated anterior segment photography, the mean PCO score with EPCO2000 program was 0.51 ±0.41 in the ZARACCOM Ultraflex group and 0.60 ±0.37 in the and TECNIS® one-piece group. There was no significant difference between the lenses for posterior capsule opacification scores at 4 weeks. Significant differences were not found between the lenses for anterior or posterior reactions in the test period.

Conclusions:

Both lenses are safe to use. Although TECNIS® one-piece has a 360Ḟ square edge, the PCO scores and of the groups were similar. And also PCO immigration areas of the lenses were generally same and the optic-haptic junction of the both lenses in rabbit model.

Financial Disclosure:

... receives consulting fees, retainer, or contract payments from a competing company, ... travel has been funded, fully or partially, by a competing company, ... research is funded, fully or partially, by a competing company

Back to previous